SG11202005381PA - Immediate-release pharmaceutical compositions containing ketoprofen lysine salt - Google Patents

Immediate-release pharmaceutical compositions containing ketoprofen lysine salt

Info

Publication number
SG11202005381PA
SG11202005381PA SG11202005381PA SG11202005381PA SG11202005381PA SG 11202005381P A SG11202005381P A SG 11202005381PA SG 11202005381P A SG11202005381P A SG 11202005381PA SG 11202005381P A SG11202005381P A SG 11202005381PA SG 11202005381P A SG11202005381P A SG 11202005381PA
Authority
SG
Singapore
Prior art keywords
immediate
pharmaceutical compositions
compositions containing
release pharmaceutical
lysine salt
Prior art date
Application number
SG11202005381PA
Inventor
Marco Cantarini
Marco Maria Gentile
Lucia Prota
Original Assignee
Dompe Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Farm Spa filed Critical Dompe Farm Spa
Publication of SG11202005381PA publication Critical patent/SG11202005381PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
SG11202005381PA 2018-01-05 2019-01-03 Immediate-release pharmaceutical compositions containing ketoprofen lysine salt SG11202005381PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18150490.3A EP3508199A1 (en) 2018-01-05 2018-01-05 Immediate-release pharmaceutical compositions containing ketoprofen lysine salt
PCT/EP2019/050097 WO2019134940A1 (en) 2018-01-05 2019-01-03 Immediate-release pharmaceutical compositions containing ketoprofen lysine salt

Publications (1)

Publication Number Publication Date
SG11202005381PA true SG11202005381PA (en) 2020-07-29

Family

ID=60935752

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202005381PA SG11202005381PA (en) 2018-01-05 2019-01-03 Immediate-release pharmaceutical compositions containing ketoprofen lysine salt

Country Status (9)

Country Link
US (1) US20210077408A1 (en)
EP (2) EP3508199A1 (en)
CN (1) CN111587108B (en)
BR (1) BR112020011573A2 (en)
CA (1) CA3085658A1 (en)
IL (1) IL275806A (en)
MA (1) MA51521A (en)
SG (1) SG11202005381PA (en)
WO (1) WO2019134940A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
WO1999052528A1 (en) * 1998-04-11 1999-10-21 Errekappa Euroterapici S.P.A. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
ES2199916T3 (en) * 2001-11-20 2004-03-01 Apr Applied Pharma Research S.A. NON-EFFECTIVE HYDROSOLUBABLE PHARMACEUTICAL COMPOSITIONS THAT INCLUDE NON-STEROID ANTI-INFLAMMATORY PHARMACES.
FR2865648B1 (en) * 2004-02-03 2006-06-30 Philippe Perovitch METHOD FOR DIFFUSION OF INSOLUBLE MOLECULES IN AQUEOUS MEDIUM AND COMPOSITION IMPLEMENTING SAID METHOD
WO2014184663A2 (en) * 2013-05-15 2014-11-20 Apr Applied Pharma Research Sa Orally dispersible drug formulations
CN104987287B (en) * 2015-06-10 2017-07-18 上海现代制药海门有限公司 A kind of preparation method of spherical Lysine m-benzoylhydratropate

Also Published As

Publication number Publication date
WO2019134940A1 (en) 2019-07-11
MA51521A (en) 2021-04-14
US20210077408A1 (en) 2021-03-18
CN111587108A (en) 2020-08-25
CA3085658A1 (en) 2019-07-11
CN111587108B (en) 2023-03-28
BR112020011573A2 (en) 2021-03-23
EP3508199A1 (en) 2019-07-10
EP3735227A1 (en) 2020-11-11
IL275806A (en) 2020-08-31
RU2020125247A (en) 2022-02-07
RU2020125247A3 (en) 2022-02-07

Similar Documents

Publication Publication Date Title
GB201807942D0 (en) Pharmaceutical formulation
SG11202010124SA (en) Stable pharmaceutical formulation
ZA202102871B (en) Pharmaceutical formulation
ZA202006570B (en) Pharmaceutical formulations
IL285674A (en) Pharmaceutical formulations
EP3851121A4 (en) Human anti-il-33 monoclonal-antibody-containing pharmaceutical composition
GB201911517D0 (en) Pharmaceutical composition
IL278927A (en) Pharmaceutical formulation
IL290894A (en) Pharmaceutical formulation
IL290469A (en) Oral pharmaceutical composition
PL3360547T3 (en) Bactericidal pharmaceutical composition comprising ibuprofen
GB201807053D0 (en) Pharmaceutical composition
SG11202103374TA (en) Pharmaceutical composition
PT3632436T (en) Pharmaceutical composition comprising lenvatinib salts
IL275806A (en) Immediate-release pharmaceutical compositions containing ketoprofen lysine salt
PL3880171T3 (en) Ibuprofen-containing oral pharmaceutical formulation
ZA202006346B (en) Pharmaceutical preparation
RS64906B1 (en) Pharmaceutical preparation
SG11202110315SA (en) Pharmaceutical composition
FI3908321T3 (en) Pharmaceutical composition
GB201906473D0 (en) Pharmaceutical formulation
SG11202101547WA (en) Pharmaceutical composition for oral administration
SG11202010792TA (en) Improved pharmaceutical formulations
IL289927A (en) New pharmaceutical formulation
SG11202010046WA (en) Pharmaceutical composition containing dipeptide